| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ASRT sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 500.0K | - | - | |
| Dir | 98.5K | $74.9K | - | |
| VP | 15.3K | - | - | |
| CFO | 14.8K | - | - | |
| COO | 5.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Stark David Matthew53 | Director | Sell | 8,959 | $0.76 | $6,806.15 | -8.3% | +0.0% | - | |
| Nov 18, 2024 | Mason Heather L49 | Director | Buy | 75,000 | $0.80 | $60,000.00 | +35.3% | -3.6% | -11.2% | |
| Nov 14, 2024 | O'Grady Brendan P. | CEO | Buy | 11,706 | $0.85 | $9,950.49 | New | +2.5% | -6.0% | |
| Jun 11, 2024 | Vacirca Jeff L | Director | Buy | 10,000 | $1.11 | $11,100.00 | +7.1% | +18.5% | -39.6% | |
| Jun 5, 2024 | Mason Heather L49 | Interim Executive Officer | Buy | 25,000 | $0.97 | $24,250.00 | +13.3% | +11.0% | -34.8% | |
| Mar 14, 2024 | Tyree James L51 | Director | Sell | 10,251 | $1.12 | $11,462.67 | -5.2% | -4.6% | -33.7% | |
| Sep 12, 2023 | Peisert Daniel A.54 | President &CEO | Sell | 158,402 | $3.03 | $479,404.91 | -32.8% | -63.0% | -57.2% | |
| Sep 11, 2023 | Schlessinger Sam | SVP, General Counsel | Sell | 45,236 | $3.04 | $137,440.54 | -39.6% | -63.9% | -59.3% | |
| Sep 11, 2023 | Patel Ajay | SVP And CAO | Sell | 64,313 | $3.04 | $195,794.50 | -40.7% | -63.9% | -59.3% | |
| Sep 11, 2023 | Schwichtenberg Paul | SVP And CFO | Sell | 104,980 | $3.07 | $322,593.04 | -62.0% | -63.9% | -59.3% |